RACHLIN EVAN LOCKWOOD purchased 38.4% of their position (718.75K shares) of IAMBIC THERAPEUTICS, INC. on the open market
Open‑market purchase worth $11.50M — a major conviction buy. The strongest form of insider conviction signal.
Common Stock
Shares
+1.46M
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+410.76K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+718.75K
Price / share
$16.00
Trade value
$11.50M
% of position
Common Stock
Shares
+57.75K
Price / share
—
Trade value
—
% of position
Net shares
+2.65M
Net value
$11.50M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 10/16/2026 | C · Conversion | +1.46M | — | — | New position | 0.00 | 1.46M |
| Common Stock Indirect | 10/16/2026 | C · Conversion | +410.76K | — | — | 28.2% | 1.46M | 1.87M |
| Common Stock Indirect | 10/16/2026 | P · Purchase | +718.75K | $16.00 | $11.50M | 38.4% | 1.87M | 2.59M |
| Common Stock Indirect | 10/16/2026 | C · Conversion | +57.75K | — | — | New position | 0.00 | 57.75K |
| Total | +2.65M | $11.50M | ||||||
Series B Convertible Preferred Stock
Common Stock
1.15M shares
Shares
−1.15M
Strike price
Held after
0.00
Exercisable
—
Series B Convertible Preferred Stock
Common Stock
57.75K shares
Shares
−57.75K
Strike price
Held after
0.00
Exercisable
—
Series B-3 Convertible Preferred Stock
Common Stock
306.71K shares
Shares
−306.71K
Strike price
Held after
0.00
Exercisable
—
Convertible Promissory Notes
Common Stock
410.76K shares
Shares
−410.76K
Strike price
Held after
0.00
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series B Convertible Preferred Stock Indirect | Common Stock1.15M shares | 10/16/2026 | C · Conversion | −1.15M | — | 0.00 | |
| Series B Convertible Preferred Stock Indirect | Common Stock57.75K shares | 10/16/2026 | C · Conversion | −57.75K | — | 0.00 | |
| Series B-3 Convertible Preferred Stock Indirect | Common Stock306.71K shares | 10/16/2026 | C · Conversion | −306.71K | — | 0.00 | |
| Convertible Promissory Notes Indirect | Common Stock410.76K shares | 10/16/2026 | C · Conversion | −410.76K | — | 0.00 |